As of May 26
| -0.05 / -2.17%|
The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +2,744.44% increase from the last price of 2.25.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.